Pro‐inflammatory monocytes are increased in Duchenne muscular dystrophy and suppressed with omega‐3 fatty acids: A double‐blind, randomized, placebo‐controlled pilot study
Autor: | Carlos Wong-Baeza, Alan Cárdenas-Conejo, Marco Antonio Villaldama-Soriano, Maricela Rodríguez-Cruz, Sthephanie Y. Hernández-De la Cruz, Tomas Almeida-Becerril |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
medicine.medical_treatment Duchenne muscular dystrophy Population Pilot Projects Inflammation Placebo Monocytes Double-Blind Method Internal medicine Fatty Acids Omega-3 medicine Humans Interleukin 6 education chemistry.chemical_classification education.field_of_study biology business.industry Monocyte medicine.disease Muscular Dystrophy Duchenne Endocrinology Cytokine medicine.anatomical_structure Neurology chemistry Dietary Supplements biology.protein Neurology (clinical) medicine.symptom business Polyunsaturated fatty acid |
Zdroj: | European Journal of Neurology. 29:855-864 |
ISSN: | 1468-1331 1351-5101 |
DOI: | 10.1111/ene.15184 |
Popis: | BACKGROUND Omega-3 long chain polyunsaturated fatty acids (LCPUFA) reduce circulating cytokines produced by monocytes. Nevertheless, whether the omega-3 LCPUFA regulate the monocytes and their cytokines in Duchenne muscular dystrophy (DMD) is unknown. The aim of this study was to evaluate whether circulating pro-inflammatory monocytes are increased and whether omega-3 LCPUFA selectively suppress these monocytes and their cytokines in patients with DMD. METHODS This was a double-blind, randomized, placebo-controlled pilot study carried out in patients with DMD supplemented with omega-3 LCPUFA (n = 6) or sunflower oils (placebo, n = 6) for 6 months. Monocytes and their cytokines were measured at baseline and after 1, 2, 3, and 6 months of supplementation. RESULTS The anti-inflammatory monocytes (median, [95% CI]) are increased at month 3 (-0.46 [-13.5-9.5] vs. 8.4 [5.5-12.5], p = 0.05) in the omega-3 LCPUFA group compared with the placebo group. The pro-inflammatory monocytes (-5.7 [-63.8-114.1] vs. -51.9 [-91.2 to -25.4], p = 0.026 and -16.4 [-50.8-50.6] vs. -57.9 [-86.9 to -18.5], p = 0.045 at months 3 and 6, respectively) and their cytokine interleukin 6 (-11.9 [-93.5-148.9] vs. -64.7 [-77.8 to -42.6], p = 0.019 at month 6) decreased in the omega-3 LCPUFA group compared with the placebo group. Pro-inflammatory monocytes decreased and anti-inflammatory monocytes were augmented (p |
Databáze: | OpenAIRE |
Externí odkaz: |